Prestige Consumer Healthcare (PBH) FY2022 results: revenue $1.1 billion, up 15.2% on the year

Prestige Consumer Healthcare Inc. (PBH) reported revenue of $1.1 billion for fiscal 2022, the year ended 31 March 2022, up 15.2% on the year before. Net income was $205 million, up 24.7%, and diluted earnings per share $4.04. The figures are the company's own, from the 10-K it filed with the SEC on 6 May 2022.

Revenue

$1.1 billion

+15.2% on the year

FY2015FY2022

Operating margin

30.4%

31.5% a year earlier

FY2015FY2022

Net income

$205 million

+24.7% on the year

FY2015FY2022

Diluted EPS

$4.04

+24.3% on the year

FY2015FY2022

this yearthe year beforeHover a bar for its figure.

The year in brief

The quarters: Q3 FY2022 · Q4 FY2022

Income statement (profit and loss)

$ million	FY2022	FY2021	FY2020	On the year
Revenue	1,087	943	963	+15.2%
Cost of revenue	466	396	411	+17.8%
Gross profit	621	547	552	+13.4%
Gross margin	57.1%	58.0%	57.3%
Operating income	330	297	291	+10.9%
Operating margin	30.4%	31.5%	30.2%
Interest expense	64.3	82.3	96.2	-21.9%
Pre-tax income	262	204	191	+28.6%
Income tax	57.1	39.4	48.9	+44.8%
Effective tax rate	21.7%	19.3%	25.6%
Net income	205	165	142	+24.7%
Net margin	18.9%	17.5%	14.8%
Diluted EPS	$4.04	$3.25	$2.78	+24.3%

$ million except per share.

Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ million	FY2022	FY2021	FY2020	On the year
Operating cash flow	260	236	217	+10.3%
Capital expenditure	9.6	22.2	14.6	-56.7%
Free cash flow	250	213	203	+17.3%
Free cash flow margin	23.0%	22.6%	21.0%
Cash from investing	-257	-22.2	-16.6
Cash from financing	-7.6	-279	-131
Depreciation and amortisation	32.1	30.2	29.0	+6.4%
Share-based compensation	9.0	8.5	7.6	+5.8%
Buybacks	0.0	11.9	56.7
Diluted shares, weighted	51m	51m	51m	+0.5%

Balance sheet

$ million	FY2022	FY2021	FY2020	On the year
Shareholders' equity	1,578	1,358	1,171	+16.1%
Debt	1,477	1,480	1,730	-0.2%
Operating lease liabilities	16.1	19.7	24.9	-18.4%
Finance lease liabilities	4.5	6.8	4.6	-34.0%
Other liabilities	596	565	583	+5.5%
Total liabilities and equity	3,671	3,429	3,514	+7.0%
Fixed assets	71.3	70.1	56.0	+1.8%
Goodwill	579	578	575	+0.2%
Intangible assets	2,697	2,476	2,479	+8.9%
Cash and equivalents	27.2	32.3	94.8	-15.8%
Receivables	139	115	151	+21.5%
Inventory	120	115	116	+4.7%
Other assets	36.9	43.5	42.0	-15.1%
Total assets	3,671	3,429	3,514	+7.0%

10-K for the year ended 31 March 2022, filed 6 May 2022: the filing.